Insider trades

Slate Path Capital, 10% Owner of Korsana Biosciences KRSA, has filed 0 purchases and 1 sale on the open market. The latest trade was on 24/11/21.

Slate Path Capital

10% Owner
First filing
24/11/25
Trades
1 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
24/11/21

Trading activity

Transactions

Trade type
Open-market sale24/11/2124/11/25357,880 sh$1.55$554,714−100.0%